Fantastic news from our affiliated company Medannex Ltd! The company has been awarded an Innovate UK ‘Transforming Cancer Therapeutics’ grant to accelerate new treatment for bone cancer in children 👏👇
We’re thrilled to announce an Innovate UK ‘Transforming Cancer Therapeutics’ grant award for a £313,000 project to tackle bone cancer in children. We’ll be working with Chris Parris' team at Anglia Ruskin University and world-leading paediatric oncologists led by Pamela Kearns to deliver this important project. Recent data mining of a paediatric genomics database and staining of tumour tissue revealed that our target, #annexin-A1, is highly expressed in #osteosarcoma, so our anti-annexin-A1 antibody (MDX-124) is a prime candidate to treat this rare disease. We’re grateful to Innovate UK for this resounding endorsement of the potential of our first-in-class therapy to make a real difference to osteosarcoma patients and their families and we’re excited to drive the project forward with the support of our scientific collaborators and specialist clinical advisors. Full story here: https://lnkd.in/ebmeK5dy Ian Abercrombie Fiona Dempsey James Ingham Henry Hays Scott Crichton Paul Flook Lisa Yule Colin Tennant